tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Asthika Goonewardene, 160 are a BUY (90.91%), 16 are a HOLD (9.09%).
Analyst Asthika Goonewardene, currently employed at TRUIST, carries an average stock price target met ratio of 43.52% that have a potential upside of 34.95% achieved within 127 days.
Asthika Goonewardene’s has documented 340 price targets and ratings displayed on 27 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ACLX, Arcellx at 24-Feb-2026.
Analyst best performing recommendations are on SMMT (SUMMIT THERAPEUTICS PLC).
The best stock recommendation documented was for SMMT (SUMMIT THERAPEUTICS PLC) at 4/10/2025. The price target of $35 was fulfilled within 14 days with a profit of $14.85 (73.7%) receiving and performance score of 52.64.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 14-Apr-2026
$6
$4.35 (263.64%)
$8
1 months 14 days ago
(17-Aug-2026)
1/12 (8.33%)
$3.92 (188.46%)
148
Buy Since 15-Apr-2026
$10
$8.35 (506.06%)
$10
5 months 9 days ago
(22-Apr-2026)
0/2 (0%)
$7.61 (318.41%)
Sell Since 16-Apr-2026
5 months 15 days ago
(16-Apr-2026)
0/3 (0%)
$2.86 (55.64%)
Buy Since 21-Nov-2022
$11
$9.35 (566.67%)
$12
5 months 15 days ago
(16-Apr-2026)
0/13 (0%)
$8.63 (364.14%)
Hold Since 21-Mar-2023
$3.85
$2.2 (133.33%)
$6
5 months 17 days ago
(14-Apr-2026)
1/2 (50%)
$1.57 (68.86%)
44
What Year was the first public recommendation made by Asthika Goonewardene?
